Apollo Neuro Partners with GOVX to Better Serve Those Who Serve Us
PITTSBURGH, Jan. 14, 2025 /PRNewswire/ -- Today, Apollo Neuroscience is proud and honored to announce our latest partnership with GOVX, an e-commerce...
Veterans
Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM
Quantum BioPharma Ltd. Dual Lists on Upstream's Global Securities Trading App TORONTO, ON / ACCESSWIRE / January 14, 2025 /...
Ex-Deep Genomics, Moderna Execs Get Backing Led by Gradient to Develop Next-Generation mRNA Therapeutics with AI
SAN FRANCISCO, Jan. 13, 2025 /PRNewswire/ -- Kerna Laboratories Inc, a San Francisco-based AI biotech startup, emerged from stealth with the...
RESTEM Provides Corporate Update and Announces Key Business Objectives for 2025
MIAMI, Jan. 10, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed...
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets...
Palvella Therapeutics Announces Publication of Results from Phase 2 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations in the Journal of Vascular Anomalies
Publication reports 100% of participants were either “Much Improved” or “Very Much Improved” as rated by the Clinician Global Impression...
UnisLink Appoints Julie Klapstein and Christine Schuster to Board of Directors
New board members provide depth in technology-enabled healthcare services, revenue cycle management, and clinical practice PHOENIX, Jan. 9, 2025 /PRNewswire/...
AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive ChairMichael Nemirow Joins as Director, Bringing Decades of...
Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid’s Emerging Role in Renal Replacement Therapy Decisions
Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal replacement therapy (CRRT) in cardiac...
Now Open: VITAS® Healthcare Inpatient Hospice Unit in Fort Worth
Freestanding homelike facility for specialized end-of-life care will serve 500+ patients annuallyFORT WORTH, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) --...
Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations
Phase 2 single-arm, baseline-controlled trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of cutaneous venous malformations...
Allied OMS Continues Strategic Expansion in Texas with Parkway Oral Surgery in Houston
SOUTHLAKE, TX and HOUSTON, TX / ACCESSWIRE / January 7, 2025 / Allied OMS, one of the country's premier management...
Quantum Biopharma Ltd. Approved to Dual List on Upstream
Trading to become available January 14th under 'QNTM' TORONTO, ONTARIO / ACCESSWIRE / January 7, 2025 / Quantum BioPharma Ltd....
Walgreens and Visory Health Ink New Deal
Walgreens’ nine million daily shoppers now have access to discounted medication through Visory Health as one of Visory Health’s Featured...
Veterans Benefits Administration awards medical disability examination services contract to Leidos QTC Health Services
RESTON, Va., Jan. 6, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the...
PharmaTher CEO Issues Letter to Shareholders
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty...
ZetrOZ Systems Presents sam(R) Technology to Leaders in Military and Professional Sports Healthcare
The creators of sustained acoustic medicine and the sam® wearable ultrasound unit connected with key user bases in military orthopedic...
WEED Inc. President and CEO Releases Letter to Shareholders
TUCSON, Ariz., Dec. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,” “HEMP” or the “Company”), a...
Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference
The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global...
CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS
Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024 /PRNewswire/ -- Caresyntax, the leading...